Indian drugmaker Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Novo Nordisk A/S’s Ozempic in March ...

Semaglutide’s U.S. patents keep generics out until around 2031 or 2035, maintaining Novo Nordisk’s exclusivity and high ...

We’ve launched a first-of-its-kind app to help you find out where your generic drugs come from and see the track records of ...

The price of semaglutide drugs could drop by more than 65% when generic versions of Ozempic and Wegovy hit shelves — possibly ...

The Food and Drug Administration on Monday announced it had approved generic versions of Vyvanse, an increasingly popular alternative to Adderall. Commonly prescribed ...

The ​Association for Accessible Medicines, which represents generic drugmakers, is expanding its roster of hired guns.

Every week through October, we are examining the medical, business and cultural systems that contribute to the dichotomy that is the American health care system — a system that benefits some but costs ...

The Supreme Court of the US (SCOTUS) has agreed to hear a patent dispute between Amarin and Hikma that could have ...

According to Nuvama, the increased competitive intensity following this approval is negative for Cipla, as it raises the risk ...

Shopping smart doesn’t mean sacrificing quality – sometimes the best deals hide in plain sight on store shelves. Generic products often deliver the same performance as their expensive counterparts, ...

Officials with the FDA have approved the first generic robenacoxib tablets for the control of postoperative pain and ...